Longevity · Longevity peptide (research)
MOTS-c
- Drug class
- Longevity peptide (research)
- Status
- Compounded (503A)
- Reviewed
- 2026-06-01 · Dr. Ana Lisa Carr, MD
What MOTS-c is studied for
- Mitochondrial health (research)
- Metabolic regulation (research)
- Exercise capacity (research)
Mechanism of action
MOTS-c is being studied in the longevity category. Mitochondrial-derived peptide for metabolic regulation and exercise capacity. Mechanism of action varies by study model; refer to the kindr clinical library for a deeper writeup.
Frequently asked questions
What is MOTS-c?
MOTS-c is a longevity peptide. Mitochondrial-derived peptide for metabolic regulation and exercise capacity.
What is MOTS-c studied for?
Published research has examined MOTS-c for mitochondrial health, metabolic regulation, exercise capacity. Human clinical evidence varies by indication.
Is MOTS-c FDA-approved?
No. MOTS-c is not FDA-approved for the indications listed. It is available compounded by 503A pharmacies under clinician supervision, or for international research use only on this catalog.
How is MOTS-c used in research?
Protocols vary by study. MOTS-c is typically administered subcutaneously in research settings. No validated human therapeutic dose exists outside FDA-approved indications.
What are the known risks?
Long-term human safety data for MOTS-c is limited. Theoretical risks vary by mechanism. Any human use should be supervised by a licensed clinician.
